Multimedia content is supported by an unrestricted educational grant from:

Scientific Agenda

Session I:
Introduction to the biology of melanoma
F. Stephen Hodi Jr., MD

Session II:
Immunotherapy: Harnessing the immune response to cancer
Jedd D. Wolchok, MD, PhD

Session III:
Overcoming immunologic tolerance to melanoma: Targeting CTLA-4
F. Stephen Hodi Jr., MD

Session IV:
Enhancing the immune response to melanoma: Vaccines and other novel biologics to stimulate and target the immune response
Vernon K. Sondak, MD